scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1035037512 |
P356 | DOI | 10.1186/AR4042 |
P932 | PMC publication ID | 3580516 |
P698 | PubMed publication ID | 23031278 |
P5875 | ResearchGate publication ID | 231860260 |
P50 | author | Derek L Mattey | Q59591523 |
P2093 | author name string | Peter T Dawes | |
Nicola B Nixon | |||
P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity | Q33359741 | ||
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 | ||
The mortality of rheumatoid arthritis | Q34338843 | ||
Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study | Q35551075 | ||
Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species. | Q35868987 | ||
Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. | Q36246052 | ||
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD. | Q37224482 | ||
The widening mortality gap between rheumatoid arthritis patients and the general population | Q38459919 | ||
Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease | Q40393362 | ||
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease | Q40596987 | ||
Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease | Q42279641 | ||
Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia | Q42437142 | ||
High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis | Q42625036 | ||
How to reduce morbidity and mortality from chest infections in rheumatoid arthritis | Q42904895 | ||
Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis | Q43709155 | ||
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. | Q43769669 | ||
Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor | Q45337810 | ||
Acute lower respiratory tract infections in patients with rheumatoid arthritis. | Q51104178 | ||
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease. | Q51479961 | ||
Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. | Q51707967 | ||
Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. | Q51835885 | ||
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. | Q51991843 | ||
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate mark | Q52980619 | ||
Absence or Inhibition of Matrix Metalloproteinase–8 Decreases Ventilator-Induced Lung Injury | Q57082623 | ||
Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort | Q57804967 | ||
Guidelines and audit measures for the specialist supervision of patients with rheumatoid arthritis. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians | Q68107428 | ||
Mortality in rheumatoid arthritis | Q68126709 | ||
Prevalence of angina as assessed by a survey of prescriptions for nitrates | Q69917748 | ||
The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales | Q70606503 | ||
Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis | Q71954108 | ||
Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome | Q72991616 | ||
Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset | Q73292550 | ||
Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD | Q73538164 | ||
Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis | Q73678542 | ||
Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity | Q73782535 | ||
The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia | Q74079346 | ||
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease | Q78394962 | ||
Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis | Q80123752 | ||
Prediction of mortality in rheumatoid arthritis based on disease activity markers | Q81463187 | ||
Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
MMP expression and abnormal lung permeability are important determinants of outcome in IPF | Q82176972 | ||
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris | Q82404817 | ||
Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury | Q82971574 | ||
Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis | Q83506210 | ||
Influence of variations across the MMP-1 and -3 genes on the serum levels of MMP-1 and -3 and disease activity in rheumatoid arthritis | Q84554453 | ||
P433 | issue | 5 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
respiratory disease | Q3286546 | ||
P304 | page(s) | R204 | |
P577 | publication date | 2012-10-02 | |
P1433 | published in | Arthritis Research and Therapy | Q15757229 |
P1476 | title | Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis | |
P478 | volume | 14 |
Q48100083 | Active matrix metalloproteinase-8 and periodontal bacteria depending on periodontal status in patients with rheumatoid arthritis |
Q38140574 | Beneficial role of vitamin D3 in the prevention of certain respiratory diseases |
Q35415454 | Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus. |
Q38239828 | Biomarkers of cartilage and surrounding joint tissue |
Q64107215 | Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus |
Q30371254 | Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis. |
Q33898784 | Immunolocalization of MMP-2 and MMP-9 in human rheumatoid synovium |
Q64277451 | Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients |
Q38111419 | Spondyloarthritis and smoking: towards a new insight into the disease |
Q41553156 | The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions |
Search more.